Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate Update

RANCHO CORDOVA, Calif., Aug. 13, 2019 /PRNewswire/ --Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced improved financial and operating results for the second quarter ended June 30, 2019 and provided a corporate update.